What is progesterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Progesterone?

Progesterone is a naturally occurring steroid hormone that is essential for reproductive function, particularly in regulating the menstrual cycle, maintaining pregnancy, and protecting the uterine lining. 1

Chemical Structure and Origin

Progesterone is a steroid hormone with the molecular formula C21H30O2 and molecular weight of 314.47 1. It is synthesized from plant-derived starting materials but is chemically identical to progesterone produced by human ovaries 1. The hormone was first isolated and characterized in 1934, with its role in maintaining uterine quiescence (keeping the uterus relaxed) first reported in 1954 2.

Primary Physiological Functions

Reproductive System

  • Controls menstrual cycle regulation through effects on luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion 3
  • Prepares and maintains the endometrium (uterine lining) for embryo implantation by promoting decidualization and exerting anti-mitogenic effects on endometrial epithelial cells 3
  • Essential for pregnancy maintenance and contributes to the onset of labor 3
  • Regulates normal menstrual bleeding patterns 3

Broader Endocrine Effects

Progesterone serves as a crucial steroidogenic precursor for other essential hormones including aldosterone, cortisol, estradiol, and testosterone 4. This makes it fundamental not just for reproduction, but for overall hormonal balance throughout the body.

Mechanisms of Action

Progesterone works primarily through progesterone receptors (PRs) that exist as two isoforms: PR-A and PR-B 2, 5. When progesterone binds to these nuclear receptors, they function as transcription factors that regulate specific gene expression 6.

Key mechanisms include:

  • Anti-inflammatory effects by decreasing prostaglandin synthesis and infection-mediated cytokine production 2
  • Maintaining uterine quiescence by altering PR-A/PR-B expression ratios 2
  • Reducing cervical stromal degradation 2
  • Decreasing contraction frequency in the myometrium (uterine muscle) 2

Clinical Formulations

Natural vs. Synthetic Forms

The term "progestogens" encompasses both natural progesterone and synthetic progestins 2. Natural progesterone can be administered in several forms:

  • Micronized progesterone: Natural progesterone processed to increase bioavailability, available as oral capsules (100 mg, 200 mg), vaginal suppositories, or gels 1, 7
  • 17-alpha-hydroxyprogesterone caproate (17P): A synthetic derivative given intramuscularly 2, 8

Important safety note: Progesterone capsules contain peanut oil and should not be used in patients with peanut allergies 1.

Clinical Applications

FDA-Approved Uses

  1. Treatment of secondary amenorrhea (absence of menstrual periods in women who previously menstruated) - typically 400 mg orally at bedtime for 10 days 1
  2. Protection of the endometrium in postmenopausal women taking estrogen - 200 mg orally at bedtime for 12 continuous days per 28-day cycle 1

Evidence-Based Obstetric Uses

  • Prevention of preterm birth in singleton pregnancies with prior spontaneous preterm birth: 17P 250 mg intramuscularly weekly from 16-20 weeks until 36 weeks 2, 8
  • Prevention of preterm birth in women with short cervical length (≤20-25 mm) at 24 weeks: Vaginal progesterone 90-mg gel or 200-mg suppository daily 2, 9

Other Endocrine Applications

Micronized progesterone is used for 3:

  • Abnormal uterine bleeding due to disordered ovulation
  • Luteal phase deficiency
  • Premenstrual syndrome
  • Functional hypothalamic amenorrhea
  • Premature ovarian insufficiency
  • Perimenopausal and menopausal symptoms

Safety Profile

Micronized natural progesterone has a superior safety profile compared to synthetic progestins 7, 3. It presents lower risks of:

  • Cardiovascular disease
  • Venous thromboembolism
  • Breast cancer
  • Metabolic disturbances

Common side effects include drowsiness and dizziness, which can be mitigated by bedtime administration 1, 3. Some women may experience blurred vision, difficulty speaking, difficulty walking, or feeling abnormal - these symptoms warrant immediate discussion with a healthcare provider 1.

Long-term safety data is reassuring: Follow-up studies of children exposed to progesterone in utero showed no differences in physical examination, health status, or developmental performance compared to placebo at 4 years of age 2.

Important Clinical Distinctions

Progesterone should not be confused with synthetic progestins (like those in Provera, PremPro), which may produce significant side effects including fatigue, fluid retention, lipid alterations, dysphoria, hypercoagulant states, and increased androgenicity 7. The molecular identity of natural progesterone to endogenous human progesterone makes it preferable for many clinical applications, particularly in women with increased cardiovascular or metabolic risk 3.

References

Research

Diagnostic and therapeutic use of oral micronized progesterone in endocrinology.

Reviews in endocrine & metabolic disorders, 2024

Research

Key to Life: Physiological Role and Clinical Implications of Progesterone.

International journal of molecular sciences, 2021

Research

Reproductive functions of progesterone receptors.

Recent progress in hormone research, 2002

Research

Mechanisms of action of estrogen and progesterone.

Annals of the New York Academy of Sciences, 2002

Research

Progesterone: review of safety for clinical studies.

Experimental and clinical psychopharmacology, 2007

Research

Technical Update No. 467: Progesterone for Previous Spontaneous Preterm Birth.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.